Results 221 to 230 of about 185,548 (298)
Synergistic effects of arsenic trioxide and atorvastatin on proliferation and apoptosis in acute lymphoblastic leukemia cells. [PDF]
Hassanpour Khodaei S +5 more
europepmc +1 more source
[Acute lymphoblastic leukemia].
P, Stavem, P F, Hjort
openaire +1 more source
Impaired hematopoiesis affects apheresis and CAR T‐cell product composition and treatment response
Abstract Background Chimeric antigen receptor (CAR) T‐cell therapy has transformed the treatment of hematologic malignancies, but its success depends on obtaining sufficient CD3+ T‐cell yields during leukapheresis. This can be difficult in heavily pretreated patients, who often show leukopenia and reduced T‐cell fitness.
Hanna Kuhn +14 more
wiley +1 more source
Daily Symptom Home Monitoring Decreases Hospital Readmissions in Children and Young Adults With Acute Lymphoblastic Leukemia. [PDF]
Ben-Kenan RF +4 more
europepmc +1 more source
The status of cell and gene therapy education in medical schools—An international survey
Abstract Introduction Cell and gene therapy (CGT) has emerged as a distinct medical field with more than 50 “Food and Drug Administration (FDA)”‐approved products treating conditions from leukemia to sickle cell disease. Despite this therapeutic revolution and the field's inherent complexity, the status of CGT education in medical schools remains ...
Edina A. Wappler‐Guzzetta +2 more
wiley +1 more source
[Acute lymphoblastic leukemia].
openaire +3 more sources
The hidden regulators: Non-coding RNAs in KMT2A-rearranged acute lymphoblastic leukemia. [PDF]
Poersch MA +5 more
europepmc +1 more source
Abstract Background Platelet transfusion refractoriness (PTR) is a major challenge in transfusion medicine and may result from both immune and non‐immune mechanisms. Although alloantibodies are well‐established contributors, Fc‐independent pathways such as platelet desialylation have emerged as alternative mechanisms of clearance.
Karen Ziza +11 more
wiley +1 more source

